Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Violation of price capping of Coronary stent to attract NPPA action; Minister

      Violation of price capping of Coronary stent to attract NPPA action; Minister

      Farhat Nasim22 Feb 2020 4:42 PM IST
      "Institutions such as hospitals/nursing homes/clinics utilizing Coronary Stents for Angioplasty are bound to abide by the ceiling prices fixed by the...
      Drug marketers to take onus for quality of drugs, regulatory compliance: Health Ministry Gazette

      Drug marketers to take onus for quality of drugs, regulatory compliance: Health Ministry Gazette

      Farhat Nasim19 Feb 2020 2:40 PM IST
      New Delhi: Through a recent gazette notification, the Union Health Ministry has amended the Drugs and Cosmetics Rules, 1945, wherein, drug...
      Prices of Paracetamol surge by 40pc as coronavirus shuts China

      Prices of Paracetamol surge by 40pc as coronavirus shuts China

      Farhat Nasim18 Feb 2020 1:21 PM IST
      Prices of paracetamol, the most commonly used analgesic, have jumped by 40% in India, while the cost of azithromycin, an antibiotic used for treating...
      CDSCO flags 34 drugs for failing quality test; Details

      CDSCO flags 34 drugs for failing quality test; Details

      Farhat Nasim15 Feb 2020 11:40 AM IST
      New Delhi: The apex drug regulator, Central Drugs Standard Control Organization (CDSCO) has flagged 34 batches of medicines for failing quality...
      CDSCO pulls manufacturers for failing to submit application for category d FDCs; Details

      CDSCO pulls manufacturers for failing to submit application for category d FDCs; Details

      Farhat Nasim14 Feb 2020 12:31 PM IST
      New Delhi: Through a recent notification, the Central Drugs Standard Control Organization (CDSCO) has pulled up the Fixed-Dose Combination (FDCs)...
      Zydus Cadila gets USFDA nod for bowel disease drug Mesalamine suppositories

      Zydus Cadila gets USFDA nod for bowel disease drug Mesalamine suppositories

      Farhat Nasim13 Feb 2020 1:04 PM IST
      "Zydus Cadila has received the final approval from the USFDA to market Mesalamine Suppositories for rectal use...1000 mg," the drug firm said in a...
      Gazette calls for registrations of medical devices, details

      Gazette calls for registrations of medical devices, details

      Farhat Nasim13 Feb 2020 11:30 AM IST
      New Delhi: Through a recent notification, the Union Health Ministry has mandated the registration of certain medical devices with the apex drug...
      All medical devices to be classified as DRUGS, details

      All medical devices to be classified as DRUGS, details

      Farhat Nasim12 Feb 2020 11:42 AM IST
      New Delhi: Through a recent gazette notification, the Union Health Ministry has notified medical equipment used on humans or animals as "drugs"...
      First of its kind: ResMed organises sleep summit in India

      First of its kind: ResMed organises sleep summit in India

      Farhat Nasim11 Feb 2020 2:54 PM IST
      On the occasion, Ms Shubhi Khurana, General Manager, India and South Asia, ResMed, said, "The idea is to bring the medical fraternity together and...
      NPPA fixes price of 21 formulations including diabetes drugs, others; Details

      NPPA fixes price of 21 formulations including diabetes drugs, others; Details

      Farhat Nasim11 Feb 2020 12:17 PM IST
      New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
      Cipla arm inks pact for anti-psychotic drug Quetiapine

      Cipla arm inks pact for anti-psychotic drug Quetiapine

      Farhat Nasim11 Feb 2020 12:15 PM IST
      New Delhi: Cipla Medpro South Africa (Pty) Ltd, a wholly-owned subsidiary of Cipla Ltd, India, has recently concluded an exclusive agreement securing...
      Coronavirus in China cause of concern for Indian Pharma Sector

      Coronavirus in China cause of concern for Indian Pharma Sector

      Farhat Nasim10 Feb 2020 8:03 PM IST
      New Delhi: Indian pharma firms are closely monitoring the outbreak of coronavirus in China as it could impact the supply of active pharmaceutical...
      Next

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok